Valuation: Carmat SA

Market Cap 61.46L 68.85L 57.12L 51.96L 97.75L 65Cr 99.51L 6.86Cr 2.68Cr 34Cr 2.58Cr 2.53Cr 108.88Cr P/E 2023
-3.09x
P/E 2024 -0.95x
Enterprise Value 5.92Cr 6.64Cr 5.51Cr 5.01Cr 9.42Cr 628.66Cr 9.59Cr 66Cr 26Cr 328.01Cr 25Cr 24Cr 1.05TCr EV / Sales 2023
56.1x
EV / Sales 2024 13.5x
Free-Float
89.06%
Yield 2023 *
-
Yield 2024 -
Current year 0.1
Extreme 0.099
0.1
1 year 0.1
Extreme 0.099
0.1
3 years 0.08
Extreme 0.085
9.99
5 years 0.08
Extreme 0.085
29.5
10 years 0.08
Extreme 0.085
40.06
Manager TitleAgeSince
Chief Executive Officer 55 01/09/2016
Director of Finance/CFO - 12/12/2018
Chief Tech/Sci/R&D Officer - 01/04/2025
Director TitleAgeSince
Director/Board Member 55 -
Director/Board Member 68 02/01/2017
Director/Board Member 79 20/04/2017
Date Insider Type Main position Quantity % Market Cap. Importance
13/03/25 Sell

Chairman

13,43,333 2.3347%
13/03/25 Buy

Chairman

13,43,333 2.3347%
29/05/24 Buy

Director

13,43,333 4.6122%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%-.--%-97.25% 70.8L
+2.12%+6.05%-19.32%+13.31% 18TCr
+1.60%+8.62%-0.03%+32.84% 12TCr
+3.87%+5.42%-21.03%+10.56% 11TCr
+0.41%+3.99%-44.97%-10.22% 7.57TCr
+1.09%+5.77%+6.35%+81.90% 6.42TCr
-1.75%-0.72%+17.66%+59.66% 5.35TCr
+2.44%+5.43%+3.16%-25.82% 5.15TCr
+2.60%+5.64%-15.19%+26.20% 4.17TCr
+3.52%+2.37%+32.11%+9.45% 3.15TCr
Average +1.59%+3.14%-4.13%+10.06% 7.25TCr
Weighted average by Cap. +1.85%+4.21%-9.97%+20.98%

Financials

2023 2024
Net sales 38.37L 42.99L 35.66L 32.44L 61.03L 41Cr 62.13L 4.28Cr 1.68Cr 21Cr 1.61Cr 1.58Cr 68Cr 73.44L 82.28L 68.26L 62.09L 1.17Cr 78Cr 1.19Cr 8.2Cr 3.21Cr 41Cr 3.09Cr 3.02Cr 130.11Cr
Net income -5.39Cr -6.04Cr -5.01Cr -4.55Cr -8.57Cr -571.61Cr -8.72Cr -60Cr -24Cr -298.24Cr -23Cr -22Cr -954.34Cr -5.14Cr -5.76Cr -4.78Cr -4.34Cr -8.17Cr -545.36Cr -8.32Cr -57Cr -22Cr -284.54Cr -22Cr -21Cr -910.51Cr
Net Debt 4.96Cr 5.56Cr 4.61Cr 4.2Cr 7.89Cr 526.69Cr 8.04Cr 55Cr 22Cr 274.8Cr 21Cr 20Cr 879.35Cr 5.31Cr 5.95Cr 4.94Cr 4.49Cr 8.45Cr 563.45Cr 8.6Cr 59Cr 23Cr 293.98Cr 22Cr 22Cr 940.72Cr
Projected Income Statement - Annual - Carmat SA
Logo Carmat SA
Carmat SA, formerly known as Carmat SAS is a France-based company engaged in the development and production of heart prosthesis. The Company is developing an orthotopic and biocompatible artificial heart which works like a natural heart, and which is hydraulically activated. It specializes in the development of a fully implantable orthotopic artificial heart, its electrical power supply system, and its telediagnosis system. The Company formed a network of partnerships with hospitals and various scientific companies, such as The Georges Pompidou European Hospital, The Marie Lannelongue Surgical Center, The Hospital Charles Nicolle of Rouen, Dedienne Sante, PaxiTech, Vignal Artru Industries, French Vessels, and Blood Institute, Laboratoire de Recherche Biochirurgicale and others.
Employees
153
  1. Stock Market
  2. Stocks
  3. ALCAR Stock